135 related articles for article (PubMed ID: 37196049)
1. Age-specific SARS-CoV-2 infection fatality rates derived from serological data vary with income and income inequality.
Rickards CG; Kilpatrick AM
PLoS One; 2023; 18(5):e0285612. PubMed ID: 37196049
[TBL] [Abstract][Full Text] [Related]
2. Variation in the COVID-19 infection-fatality ratio by age, time, and geography during the pre-vaccine era: a systematic analysis.
COVID-19 Forecasting Team
Lancet; 2022 Apr; 399(10334):1469-1488. PubMed ID: 35219376
[TBL] [Abstract][Full Text] [Related]
3. SARS-CoV-2 infection fatality rate after the first epidemic wave in Mexico.
Torres-Ibarra L; Basto-Abreu A; Carnalla M; Torres-Alvarez R; Reyes-Sanchez F; Hernández-Ávila JE; Palacio-Mejia LS; Alpuche-Aranda C; Shamah-Levy T; Rivera JA; Barrientos-Gutierrez T
Int J Epidemiol; 2022 May; 51(2):429-439. PubMed ID: 35157072
[TBL] [Abstract][Full Text] [Related]
4. Estimating effective infection fatality rates during the course of the COVID-19 pandemic in Germany.
Staerk C; Wistuba T; Mayr A
BMC Public Health; 2021 Jun; 21(1):1073. PubMed ID: 34090392
[TBL] [Abstract][Full Text] [Related]
5. Estimating global, regional, and national daily and cumulative infections with SARS-CoV-2 through Nov 14, 2021: a statistical analysis.
COVID-19 Cumulative Infection Collaborators
Lancet; 2022 Jun; 399(10344):2351-2380. PubMed ID: 35405084
[TBL] [Abstract][Full Text] [Related]
6. Representative estimates of COVID-19 infection fatality rates from four locations in India: cross-sectional study.
Cai R; Novosad P; Tandel V; Asher S; Malani A
BMJ Open; 2021 Oct; 11(10):e050920. PubMed ID: 34610940
[TBL] [Abstract][Full Text] [Related]
7. Estimating the infection-fatality risk of SARS-CoV-2 in New York City during the spring 2020 pandemic wave: a model-based analysis.
Yang W; Kandula S; Huynh M; Greene SK; Van Wye G; Li W; Chan HT; McGibbon E; Yeung A; Olson D; Fine A; Shaman J
Lancet Infect Dis; 2021 Feb; 21(2):203-212. PubMed ID: 33091374
[TBL] [Abstract][Full Text] [Related]
8. Pandemic preparedness and COVID-19: an exploratory analysis of infection and fatality rates, and contextual factors associated with preparedness in 177 countries, from Jan 1, 2020, to Sept 30, 2021.
COVID-19 National Preparedness Collaborators
Lancet; 2022 Apr; 399(10334):1489-1512. PubMed ID: 35120592
[TBL] [Abstract][Full Text] [Related]
9. A Bayesian estimate of the early COVID-19 infection fatality ratio in Brazil based on a random seroprevalence survey.
Marra V; Quartin M
Int J Infect Dis; 2021 Oct; 111():190-195. PubMed ID: 34390858
[TBL] [Abstract][Full Text] [Related]
10. COVID-19 pandemic in Saint Petersburg, Russia: Combining population-based serological study and surveillance data.
Barchuk A; Skougarevskiy D; Kouprianov A; Shirokov D; Dudkina O; Tursun-Zade R; Sergeeva M; Tychkova V; Komissarov A; Zheltukhina A; Lioznov D; Isaev A; Pomerantseva E; Zhikrivetskaya S; Sofronova Y; Blagodatskikh K; Titaev K; Barabanova L; Danilenko D
PLoS One; 2022; 17(6):e0266945. PubMed ID: 35704649
[TBL] [Abstract][Full Text] [Related]
11. Age-stratified infection fatality rate of COVID-19 in the non-elderly population.
Pezzullo AM; Axfors C; Contopoulos-Ioannidis DG; Apostolatos A; Ioannidis JPA
Environ Res; 2023 Jan; 216(Pt 3):114655. PubMed ID: 36341800
[TBL] [Abstract][Full Text] [Related]
12. Estimates and Determinants of SARS-Cov-2 Seroprevalence and Infection Fatality Ratio Using Latent Class Analysis: The Population-Based Tirschenreuth Study in the Hardest-Hit German County in Spring 2020.
Wagner R; Peterhoff D; Beileke S; Günther F; Berr M; Einhauser S; Schütz A; Niller HH; Steininger P; Knöll A; Tenbusch M; Maier C; Korn K; Stark KJ; Gessner A; Burkhardt R; Kabesch M; Schedl H; Küchenhoff H; Pfahlberg AB; Heid IM; Gefeller O; Überla K
Viruses; 2021 Jun; 13(6):. PubMed ID: 34200766
[TBL] [Abstract][Full Text] [Related]
13. Dynamics of SARS-CoV-2 infection hospitalisation and infection fatality ratios over 23 months in England.
Eales O; Haw D; Wang H; Atchison C; Ashby D; Cooke GS; Barclay W; Ward H; Darzi A; Donnelly CA; Chadeau-Hyam M; Elliott P; Riley S
PLoS Biol; 2023 May; 21(5):e3002118. PubMed ID: 37228015
[TBL] [Abstract][Full Text] [Related]
14. Reconciling estimates of global spread and infection fatality rates of COVID-19: An overview of systematic evaluations.
Ioannidis JPA
Eur J Clin Invest; 2021 May; 51(5):e13554. PubMed ID: 33768536
[TBL] [Abstract][Full Text] [Related]
15. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Fatality Rate Among Elderly Danes: A Cross-sectional Study on Retired Blood Donors.
Pedersen OB; Nissen J; Dinh KM; Schwinn M; Kaspersen KA; Boldsen JK; Didriksen M; Dowsett J; Sørensen E; Thørner LW; Larsen MAH; Grum-Schwensen B; Sækmose S; Paulsen IW; Frisk NLS; Brodersen T; Vestergaard LS; Rostgaard K; Mølbak K; Skov RL; Erikstrup C; Ullum H; Hjalgrim H
Clin Infect Dis; 2021 Nov; 73(9):e2962-e2969. PubMed ID: 33103182
[TBL] [Abstract][Full Text] [Related]
16. Infection fatality rate of COVID-19 in community-dwelling elderly populations.
Axfors C; Ioannidis JPA
Eur J Epidemiol; 2022 Mar; 37(3):235-249. PubMed ID: 35306604
[TBL] [Abstract][Full Text] [Related]
17. Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality, 2020-21.
COVID-19 Excess Mortality Collaborators
Lancet; 2022 Apr; 399(10334):1513-1536. PubMed ID: 35279232
[TBL] [Abstract][Full Text] [Related]
18. Assessing the burden of COVID-19 in developing countries: systematic review, meta-analysis and public policy implications.
Levin AT; Owusu-Boaitey N; Pugh S; Fosdick BK; Zwi AB; Malani A; Soman S; Besançon L; Kashnitsky I; Ganesh S; McLaughlin A; Song G; Uhm R; Herrera-Esposito D; de Los Campos G; Peçanha Antonio ACP; Tadese EB; Meyerowitz-Katz G
BMJ Glob Health; 2022 May; 7(5):. PubMed ID: 35618305
[TBL] [Abstract][Full Text] [Related]
19. Age- & sex-specific infection fatality ratios for COVID-19 estimated from two serially conducted community-based serosurveys, Chennai, India, 2020.
Vivian Thangaraj JW; Kumar MS; Velusamy S; Girish Kumar CP; Selvaraju S; Sabarinathan R; Jagadeesan M; Hemalatha MS; Bhatnagar T; Murhekar MV
Indian J Med Res; 2021 May; 153(5&6):546-549. PubMed ID: 34528527
[TBL] [Abstract][Full Text] [Related]
20. Trends in seroprevalence of SARS-CoV-2 and infection fatality rate in the Norwegian population through the first year of the COVID-19 pandemic.
Tunheim G; Rø GØI; Tran T; Kran AB; Andersen JT; Vaage EB; Kolderup A; Vaage JT; Lund-Johansen F; Hungnes O
Influenza Other Respir Viruses; 2022 Mar; 16(2):204-212. PubMed ID: 34751488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
